Akebia Therapeutics Balance Sheet - Quarterly (NASDAQ:AKBA)

Add to My Stocks
$7.74 $0.04 (0.51%) AKBA stock closing price Sep 19, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Akebia Therapeutics balance sheet. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Akebia Therapeutics stock analysis, and provides insights into the firm's financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Akebia Therapeutics had a long term debt of $- at the end of 2018 Q2. To understand the debt servicing capacity of the company, one needs to look at Akebia Therapeutics operating cash flow and Akebia Therapeutics revenue also. Akebia Therapeutics debt to equity ratio is 0.

View and download Akebia Therapeutics quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash163.53M158.17M70.15M89.59M125.39M87.25M187.33M65.83M46.17M43.43M
Marketable Securities238.6M234.85M247.63M240.1M195.82M164.55M73M95.49M142.47M173.58M
Receivables-35.85M34.21M---33.82M---
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets5.16M8.1M6.34M3.95M11.17M3.24M2.15M3.82M3.87M2.5M
Total Current Assets
407.42M436.98M358.35M333.93M332.38M255.05M296.32M165.14M192.52M219.53M
Property Plant & Equipment5.2M4.97M4.67M-3.62M3.48M3.05M3M--
Accumulated Depreciation1.47M1.25M1.05M-------
Net Property Plant & Equipment
3.73M3.71M3.61M3.36M2.93M2.9M2.61M2.68M1.83M-
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets2.64M2.01M2.27M1.28M1.49M1.29M1.28M1.28M1.28M1.28M
Total Assets
413.78M442.71M364.24M338.58M336.82M259.25M300.21M169.11M195.63M221.44M
Notes Payable----------
Accounts Payable4.8M17.88M6.99M8.7M10.21M15.08M2.03M8.52M5.14M2.41M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses81.01M54.94M52.44M21.42M28.85M34.27M30.26M17.61M15.78M10.99M
Income Taxes Payable----------
Other Current Liabilities78.61M78.59M84.91M121.22M142.52M84.1M81.96M---
Total Current Liabilities
164.42M151.41M144.34M151.35M181.59M133.46M114.26M26.13M20.93M13.4M
Mortgages----------
Deferred Taxes/Income83.37M94.17M100.54M87.33M98.2M95.15M117.8M42.26M41.4M40.25M
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
247.86M245.61M244.91M238.71M279.82M228.63M232.09M68.4M62.34M53.67M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus594.68M591.87M493.82M486.38M420.44M372.47M365.29M359.99M356.21M355.13M
Retained Earnings-428.29M-394.22M-374.05M-386.33M-363.19M-341.67M-297.13M-259.27M-222.96M-187.18M
Treasury Stock----------
Other Liabilities-0.46M-0.55M-0.44M-0.18M-0.25M-0.17M-0.04M-0.01M--0.02M
Shareholders Equity165.92M197.09M119.33M99.87M56.99M30.61M68.12M100.71M133.28M167.76M
Total Liabilities & Shareholders Equity413.78M442.71M364.24M338.58M336.82M259.25M300.21M169.11M195.63M221.44M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Akebia Therapeutics stock price, and Akebia Therapeutics historical stock prices show the stock price movement over time, and the Akebia Therapeutics PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: AKBA total assets, which was at $413.78M for 2018 Q2 is a balance sheet item representing value of what Akebia Therapeutics owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of Akebia Therapeutics for the quarter 2018 Q2 total to $247.86M. Liabilities for a company like Akebia Therapeutics include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Akebia Therapeutics Balance Sheet - Key Ratios

Current ratio
2.48
Debt to equity ratio
0
Asset turnover ratio
0.46
Receivables turnover
15.85
Price to book ratio
3.44